Home News Company news...
March 27, 2024

Glymate Honored with 2024 Global Recognition AwardTM

New York, United States - March 22, 2024 - Glymate, a leading figure in the dietary supplement market, has been awarded the prestigious 2024 Global Recognition Award™.  This honor celebrates Glymate's substantial contributions to the dietary supplement industry and marks a significant milestone in its quest for excellence.

Glymate's success at the Global Recognition Awards™ is attributed to its pioneering approach to dietary supplements. "Our dedication to excellence and innovation is at the core of everything we do," said Jack Wang, General Manager of Meborium Inc. The company is renowned for its robust research and development, ensuring that each product not only meets but exceeds the highest standards of efficacy and quality.

The award recognizes Glymate's commitment to sustainable and ethical business practices, distinguishing it from competitors and aligning with the values of consumers who prioritize environmental and social responsibility.

Looking forward, Glymate is poised for further innovation and expansion, with plans to extend its product line and reach new markets globally. As the importance of health and wellness continues to grow worldwide, Glymate's role in providing top-tier supplements becomes increasingly vital.

Alex Sterling, spokesperson for the Global Recognition Awards™, noted, "Glymate's achievement is a clear indication of the company's industry leadership and commitment to quality. They set a high standard for others to follow."

 

Some context:

Glymate Wins a 2024 Global Recognition Award(TM)

https://markets.businessinsider.com/news/stocks/glymate-wins-a-2024-global-recognition-award-tm-1033186930

 


 

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, Mebo Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, Mebo focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, Mebo's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.

 

About Glymate

Glymate is a new dietary supplement that utilizes a blend of natural ingredients to help prevent abnormal blood sugar levels. With regular use, it can maintain healthy levels of blood sugar, insulin, and lipid metabolism, and assist in maintaining a healthy weight. Its patented formula and natural components make it a trusted choice for consumers.

Meborium Inc., a subsidiary of MEBO International and renowned U.S. pharmaceutical company Robinson Pharma, collaborate to adhere to FDA and California Department of Health regulations, ensuring rigorous management throughout the manufacturing process. Glymate also contains MEBO's proprietary gastrointestinal regenerative nutritional compound, which helps prevent mucosal damage, protect gastrointestinal function, and enhance the solubility and absorption of active ingredients.

 

About Global Recognition AwardsTM

Global Recognition AwardsTM is an international organization that recognizes exceptional companies and individuals who have significantly contributed to their industry. Their awards are highly regarded and sought after by businesses across the globe.